Andy Billinton Selected Research

Hypersensitivity (Allergy)

9/2008	The putative cannabinoid receptor GPR55 plays a role in mechanical hyperalgesia associated with inflammatory and neuropathic pain.
8/2008	Novel histamine H3 receptor antagonists GSK189254 and GSK334429 are efficacious in surgically-induced and virally-induced rat models of neuropathic pain.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andy Billinton Research Topics

Disease

7	Pain (Aches) 01/2018 - 08/2008
3	Neuralgia (Stump Neuralgia) 01/2019 - 08/2008
2	Inflammation (Inflammations) 05/2024 - 09/2008
2	Alzheimer Disease (Alzheimer's Disease) 11/2023 - 01/2023
2	Neurodegenerative Diseases (Neurodegenerative Disease) 11/2023 - 01/2023
2	Hypersensitivity (Allergy) 09/2008 - 08/2008
2	Hyperalgesia 09/2008 - 07/2008
1	Infections 05/2024
1	Animal Disease Models 05/2024
1	Multiple Sclerosis 11/2023
1	Neuroinflammatory Diseases 11/2023
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2023
1	Parkinson Disease (Parkinson's Disease) 11/2023

Drug/Important Bio-Agent (IBA)

2	CytokinesIBA 05/2024 - 09/2008
2	InflammasomesIBA 05/2024 - 11/2023
2	SodiumIBA 05/2024 - 05/2009
2	LigandsIBA 01/2018 - 09/2008
2	Freund's AdjuvantIBA 08/2010 - 07/2008
1	InterleukinsIBA 05/2024
1	Amyloid (Amyloid Fibrils)IBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	AntibodiesIBA 01/2019
1	Ligand-Gated Ion ChannelsIBA 01/2019
1	Acetic Acid (Vinegar)FDA LinkGeneric 01/2018
1	GSK726701AIBA 01/2018
1	benzofuranIBA 07/2011
1	Pyrrolidonecarboxylic Acid (Pyroglutamic Acid)IBA 09/2010
1	AmidesIBA 09/2010
1	sodium 6- ((5- chloro- 2- (((4- chloro- 2- fluorophenyl)methyl)oxy)phenyl)methyl)- 2- pyridinecarboxylateIBA 05/2009
1	6- (2- (5- chloro- 2- (((2,4- difluorophenyl)methyl)oxy)phenyl)- 1- cyclopenten- 1- yl)- 2- pyridinecarboxylic acidIBA 05/2009
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 09/2008
1	Analgesics (Analgesic Drugs)IBA 09/2008
1	Cannabinoid Receptors (Cannabinoid Receptor)IBA 09/2008
1	Histamine (Histamine Dihydrochloride)FDA Link 08/2008
1	1- (1- methylethyl)- 4- ((1- (6- (trifluoromethyl)- 3- pyridinyl)- 4- piperidinyl)carbonyl)hexahydro- 1H- 1,4- diazepineIBA 08/2008
1	6- ((3- cyclobutyl- 2,3,4,5- tetrahydro- 1H- 3- benzazepin- 7- yl)oxy)- N- methyl- 3- pyridinecarboxamideIBA 08/2008
1	Histamine H3 AntagonistsIBA 08/2008
1	Niacinamide (Nicotinamide)FDA LinkGeneric 08/2008
1	Cholinergic ReceptorsIBA 07/2008

Therapy/Procedure

2	Therapeutics 05/2024 - 08/2012
1	Analgesia 01/2019
1	Ligation 09/2008
1	Oral Administration 08/2008